Total investments 20
Average round size 
$33M
The average size of a deal this fund participated in
Portfolio companies 17
Lead investments 1
Follow on index
0.15How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees 6
Shanghai, China Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Jianxin Capital:
Typical Co-investors
Jianxin Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Jianxin Capital:
There are no funds here. If we find new data, we will add it here.
Funds with similar focus
Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Allegis Capital | California, San Francisco, United States |
| Biomatics Capital Partners | Seattle, United States, Washington |
| Cathay Capital | Beijing, Beijing, China |
| Changxiang Entertainment | Beijing, China, Shijingshan |
| Citizens National Bank | Fort Worth, Texas, United States |
| FacePaint | New York, New York, United States |
| Florida Growth Fund | Florida, Fort Lauderdale, United States |
| G2H2 Capital | New York, New York, United States |
| Guava Capital | - |
| Haier Open Partnership Ecosystem (HOPE) | China, Japan, Kagoshima Prefecture |
| Hokkaido Venture Capital | Hokkaido Prefecture, Japan, Sapporo |
| Lafayette Group | United States, Vienna, Virginia |
| Nazca Ventures | - |
| Norvestor Equity | Norway, Oslo |
| Sagene Tech Ventures | Norway, Oslo |
| Shenzhen Wangyu | China, Guangdong, Shenzhen |
| Stahl Invest | - |
| Stonewood Capital Management | Pennsylvania, Pittsburgh, United States |
| Winfield Capital Corp | New York, United States, White Plains |
Team
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Hegea Bio | $15M | 28 Mar 2024 | Shanghai, Shanghai, China | ||
Isabers | $34M | 18 May 2023 | Beijing, Beijing, China | ||
Meike Solar | $185M | 21 Dec 2021 | Yangzhong, Jiangsu, China | ||
Abbisko Therapeutics | $70M | 25 Mar 2020 | China, Shanghai | ||
Leads Biolabs | 29 Aug 2018 | Nanjing, Jiangsu, China | |||
Sumgen Biotech | $7M | 27 Jul 2018 | China, Zhejiang | ||
Eastern Biotech | $463K | 06 Feb 2018 | Dongcheng District, Beijing, China | ||
Huadao Biopharma | $463K | 08 Nov 2017 | Shanghai, China | ||
Leads Biolabs | 03 Jul 2017 | Nanjing, Jiangsu, China |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Related media
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Jianxin Capital?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 20
Average round size 33M
Peak activity year 2015
Lead investments 1
Follow on index 0.15
Exits 3
Group Appearance index 0.85
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Hegea Bio | $15M | 28 Mar 2024 | Shanghai, Shanghai, China | ||
Isabers | $34M | 18 May 2023 | Beijing, Beijing, China | ||
Meike Solar | $185M | 21 Dec 2021 | Yangzhong, Jiangsu, China | ||
Abbisko Therapeutics | $70M | 25 Mar 2020 | China, Shanghai | ||
Leads Biolabs | 29 Aug 2018 | Nanjing, Jiangsu, China | |||
Sumgen Biotech | $7M | 27 Jul 2018 | China, Zhejiang | ||
Eastern Biotech | $463K | 06 Feb 2018 | Dongcheng District, Beijing, China | ||
Huadao Biopharma | $463K | 08 Nov 2017 | Shanghai, China | ||
Leads Biolabs | 03 Jul 2017 | Nanjing, Jiangsu, China |
